Crescent Sterling’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $294K | Sell |
6,359
-707
| -10% | -$32.7K | 0.33% | 63 |
|
|
2025
Q1 | $431K | Hold |
7,066
| – | – | 0.44% | 53 |
|
|
2024
Q4 | $400K | Sell |
7,066
-109
| -2% | -$6.17K | 0.41% | 55 |
|
|
2024
Q3 | $371K | Sell |
7,175
-1,998
| -22% | -$103K | 0.35% | 61 |
|
|
2024
Q2 | $381K | Sell |
9,173
-874
| -9% | -$36.3K | 0.36% | 60 |
|
|
2024
Q1 | $545K | Sell |
10,047
-80
| -0.8% | -$4.34K | 0.5% | 52 |
|
|
2023
Q4 | $520K | Sell |
10,127
-100
| -1% | -$5.13K | 0.52% | 48 |
|
|
2023
Q3 | $594K | Sell |
10,227
-897
| -8% | -$52.1K | 0.63% | 43 |
|
|
2023
Q2 | $711K | Buy |
11,124
+75
| +0.7% | +$4.8K | 0.68% | 40 |
|
|
2023
Q1 | $766K | Buy |
11,049
+841
| +8% | +$58.3K | 0.74% | 41 |
|
|
2022
Q4 | $734K | Buy |
+10,208
| New | +$734K | 0.79% | 39 |
|